Advanced Energy
AEIS
$211.56
-11.15%
Advanced Energy Industries designs, manufactures, and services precision power conversion, measurement, and control equipment — plasma power products, AC-DC power supplies, DC-DC converters, high-voltage systems, and SCR controllers — that transform raw electricity into tightly controlled power for semiconductor fabrication tools, data center computing, industrial and medical equipment, and telecom networks. The company is a niche-to-mid-tier supplier embedded in the semiconductor capital equipment supply chain, where its engineering depth and qualification cycles create sticky customer relationships, while its data center power franchise positions it as a picks-and-shovels beneficiary of AI infrastructure buildouts. The current investor debate centers on whether AEIS's explosive fiscal 2026 growth — Q3 revenue up 50.3% year over year to $696.4M with semiconductor equipment and data center computing as the twin engines — is a durable structural re-rating or a cyclical peak, a tension sharpened by the stock's 32% six-month decline despite the strong fundamental print. Recent headlines such as Zacks' "AEIS Q3 Earnings Beat on Semiconductor and Data Center Strength" underscore the disconnect between record operating results and a share price that has de-rated sharply, with investors now focused on forward order visibility, margin sustainability, and the balance-sheet transformation following the debt repayment and cash build in Q2.…
AEIS
Advanced Energy
$211.56
Related headlines
Investment Opinion: Should I buy AEIS Today?
Rating: Buy, with position sizing discipline. The thesis in one sentence: AEIS is a structurally improving power-conversion supplier whose Q3 2026 revenue grew 50.3% to $696.4M and net margin doubled to 16.6%, yet the stock trades at just 13.5x forward EPS of $20.51 — a 75% discount to its 53.0x trailing multiple — while 11 of 12 analysts rate it Buy with a $388.17 average target implying +63.0% upside from $238.10. The consensus recommendation mean of 1.33 (strong buy) and the fact that even the $275 low target sits 15.5% above the current price anchor the view that the 32.3% six-month decline has overshot the fundamental improvement.
Supporting evidence is unusually concrete for a stock this beaten down. First, valuation: forward PE of 13.5x against trailing 53.0x, a PEG of 0.31, and EV/Sales of 4.26x for a company growing revenue 50.3% — cheap on growth-adjusted terms if estimates hold. Second, the growth trajectory is accelerating, not fading: quarterly revenue rose from $511.0M (Q1) to $574.1M (Q2) to $696.4M (Q3), with semiconductor equipment at $322.2M (46%) and data center computing at $256.2M (37%) compounding together. Third, profitability inflected hard — gross margin 41.51% vs 38.83% a year ago, operating margin 20.56% vs 10.62%, EBITDA $172.1M (24.7% margin) vs $67.4M (14.5%). Fourth, the balance sheet was transformed by Q2's $1.13B debt repayment, leaving $1.43B cash, debt-to-equity of 0.498, current ratio of 1.59, and interest coverage near 47.7x. The soft spot is cash conversion: TTM free cash flow of $71.8M against $115.6M of quarterly net income, with $100.2M absorbed by working capital (inventory +$105.7M, receivables +$69.2M).
Three risks could invalidate the thesis: (1) margin mean-reversion — if the 41.51% gross margin falls back toward the 37-39% historical band, the 13.5x forward multiple becomes a value trap rather than a bargain; (2) end-market concentration — 83% of revenue sits in two cyclical markets, so an AI infrastructure digestion phase would hit the majority of the top line at once; (3) cash conversion — if FCF stays near $71.8M TTM while earnings run at a $460M+ annualized pace, the growth is being financed rather than earned. Conditions for a rating change: upgrade to a higher-conviction Buy if Q4 gross margin holds above 40% and FCF conversion improves toward 60%+ of net income; downgrade to Hold if revenue growth decelerates below 20% or gross margin breaks below 38%. Valuation verdict: undervalued on forward earnings relative to its own multi-year band (roughly 18x-53x trailing) and to its growth rate, but fairly-to-fully priced if Q3 margins prove peak-cycle — the stock is priced for execution, not for perfection.
Sign up to view all
AEIS 12-Month Price Forecast
The forward-looking case is bullish but sized for volatility: the fundamental evidence — 50.3% revenue growth, a doubling of net margin to 16.6%, and a 13.5x forward multiple against a 53.0x trailing one — outweighs the technical damage of a 32.3% six-month decline and a -44.32% max drawdown. The November 3 high-volume reversal (+9.63% to $238.10 off a $216.63 low) suggests capitulation selling found a bid, and the fact that even the $275 analyst low target is above the current price argues the selloff has overshot. The key uncertainty is margin durability: if the 41.51% gross margin holds, the stock is genuinely cheap; if it mean-reverts toward 37-39%, the forward multiple is a value trap. I would upgrade to high confidence if Q4 guidance confirms sequential growth above $696.4M with gross margin above 40%, and downgrade to neutral if revenue growth decelerates below 20% or free cash flow fails to improve from the $71.8M TTM level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Advanced Energy's 12-month outlook, with a consensus price target around $388.17 and implied upside of +83.5% versus the current price.
Average Target
$388.17
12 analysts
Implied Upside
+83.5%
vs. current price
Analyst Count
12
covering this stock
Price Range
$275 - $535
Analyst target range
Coverage is robust with 12 analysts and an overwhelmingly bullish tilt: 11 Buy ratings, 1 Hold, 0 Sell, a recommendation mean of 1.33 (strong buy), and an average target price of $388.17 — implying +63.0% upside from the current $238.10. The consensus is clearly leaning bullish, and the recent institutional ratings flow supports that stance: Baird reiterated Outperform on November 3, Seaport Global upgraded to Buy from Neutral on August 5, Wells Fargo upgraded to Overweight from Equal Weight on July 1, and Citigroup, Morgan Stanley, Needham, and Cantor Fitzgerald have all maintained Buy/Overweight/Positive ratings through the summer. The lone Hold from TD Cowen marks the skeptical fringe.
The target range of $275.00 to $535.00 is exceptionally wide — a 95% spread from low to high — signaling high uncertainty about the durability of the earnings ramp. The $535 high target implies multiple expansion on top of the forward EPS of $20.51 (roughly 26x forward earnings) and assumes data center and semiconductor demand sustain the 50% growth trajectory with margins holding above 20%; the $275 low target, still 15.5% above the current price, prices in margin compression and a return toward mid-cycle earnings power. The fact that even the low target sits above the current price is a strong signal that the selloff has overshot fundamental expectations, but the wide dispersion and the stock's 1.37 beta mean investors should expect continued volatility around the November 3 post-earnings reversal as the market digests whether the Q3 beat is a new baseline or a cyclical peak.
Drowning in data?
Find the real signal!
Bulls vs Bears: AEIS Investment Factors
The bull case currently rests on stronger hard evidence: 50.3% revenue growth, a 16.6% net margin versus 10.0% a year ago, and a forward PE of 13.5x against a 53.0x trailing multiple, all corroborated by 11 of 12 analysts rating the stock Buy with a $388.17 average target. The bear case is primarily price-action and quality-of-earnings driven — a 32.3% six-month decline, a -44.32% max drawdown, and TTM free cash flow of just $71.8M against $115.6M of quarterly net income — rather than a refutation of the fundamental print. The single most important tension is whether Q3's 41.51% gross margin and 20.56% operating margin represent a durable structural re-rating or a cyclical peak; if margins hold, the 13.5x forward multiple is genuinely cheap, but if they mean-revert, that multiple is a value trap. The wide $275-$535 target range captures exactly this uncertainty, and the November 3 high-volume reversal candle (+9.63% to $238.10 off a $216.63 low) suggests capitulation selling may have found a bid, but the trend is not yet repaired. On balance, the fundamental evidence outweighs the technical damage, though conviction should be sized for a 1.37 beta and continued volatility around the post-earnings reversal.
Bullish
- Revenue accelerating at 50% YoY: Q3 2026 revenue of $696.4M grew 50.3% year over year from $463.3M, and the sequential cadence ($511.0M in Q1, $574.1M in Q2, $696.4M in Q3) shows acceleration rather than deceleration. Each quarter added roughly $60-120M, confirming that semiconductor equipment ($322.2M, 46% of revenue) and data center computing ($256.2M, 37%) are compounding together.
- Forward PE of 13.5x vs 53.0x trailing: The trailing PE of 53.0x collapses to a forward PE of 13.5x on consensus EPS of $20.51, a 75% compression that implies the market expects earnings to roughly quadruple. The PEG ratio of 0.31 screens as deeply undervalued on growth-adjusted terms if those forward estimates are achievable.
- Margin expansion is broad-based: Gross margin expanded to 41.51% from 38.83% a year ago, operating margin reached 20.56% versus 10.62%, and EBITDA nearly tripled to $172.1M (24.7% margin) from $67.4M (14.5%). Q3 net income of $115.6M on a 16.6% net margin compares with $46.2M and 10.0% a year ago, reflecting operating leverage on the 50% revenue growth.
- Analyst consensus strongly bullish: Eleven of 12 analysts rate AEIS Buy with zero Sells, a recommendation mean of 1.33 (strong buy), and an average target of $388.17 implying +63.0% upside from $238.10. Even the low target of $275 sits 15.5% above the current price, a strong signal the selloff has overshot fundamental expectations.
Bearish
- Stock down 32% in six months: Despite the record Q3 print, AEIS has fallen 32.3% over six months and 27.7% over three months, lagging SPY by 25.7 points over three months. The -44.32% maximum drawdown from the June peak of $388.23 signals distribution rather than a garden-variety pullback, and the stock trades at only 24% of its 52-week range.
- Free cash flow conversion is weak: TTM free cash flow is just $71.8M against $115.6M of quarterly net income, with Q3 FCF of $34.0M versus operating cash flow of $65.1M. Working capital absorbed $100.2M (inventory up $105.7M, receivables up $69.2M), and ROE of 10.89% and ROA of 6.25% sit well below what 20%+ operating margins would suggest.
- Two end markets drive the story: Semiconductor equipment (46%) and data center computing (37%) together account for 83% of revenue, while industrial and medical (13%) and telecom and networking (4%) are drags. This concentration in two cyclical end markets raises the risk that a single demand air-pocket — particularly an AI infrastructure digestion phase — could reverse the growth trajectory quickly.
- Wide 95% analyst target dispersion: Targets range from $275 to $535, a 95% spread that signals high uncertainty about the durability of the earnings ramp. The $275 low target prices in margin compression and a return toward mid-cycle earnings power, implying the market genuinely doubts whether Q3 margins are a new baseline or a cyclical peak.
AEIS Technical Analysis
AEIS is in a confirmed intermediate downtrend despite a still-positive long-term tape: the stock is up 15.8% over the past year but sits at $238.10, only 20.1% above its 52-week low of $187.71 and 40.1% below its 52-week high of $397.44 — meaning it trades at roughly 24% of its 52-week range, deep in the lower quartile. That positioning reflects a violent round-trip from the mid-year highs near $388 in late June, with a maximum drawdown of -44.32% from peak to trough, a magnitude that signals distribution rather than a garden-variety pullback. The stock is now testing the lower boundary of its range, a zone where either a durable base forms or the falling knife continues.
Short-term momentum is decisively negative and diverging sharply from the 1-year trend: the stock is down 21.7% over the past month, 27.7% over three months, and 32.3% over six months, versus a 1-year gain of 15.8% — a classic deceleration pattern where the trailing-year return is being rapidly eroded. Relative strength confirms the underperformance, with AEIS lagging SPY by 19.8 points over one month and 25.7 points over three months, even as SPY itself fell just 2.0% and 2.0% respectively. The one offsetting datapoint is the most recent session: shares jumped 9.63% on November 3 to $238.10 from $217.19 on volume of roughly 1.24M shares, a high-volume reversal candle off the $216.63 low that suggests capitulation-style selling may have found a bid near the October lows.
Key technical levels are well defined: support sits at the October closing low of $216.63 and the 52-week low of $187.71, while resistance is anchored at the $280-$290 shelf (the September consolidation zone) and ultimately the $397.44 high. A decisive break below $216.63 would open the door to the $187.71 low and confirm the downtrend's continuation, whereas reclaiming $280 would signal a trend-repair attempt. With a beta of 1.37, AEIS is roughly 37% more volatile than the market, so position sizing should assume amplified drawdowns — the -44.32% max drawdown is a live illustration of that risk, and the 2.8 short ratio indicates short interest is moderate but not extreme, leaving room for further squeeze-driven rallies like the one just seen.
Beta
—
—
Max Drawdown
-45.6%
Largest decline past year
52-Week Range
$188-$397
Price range past year
Annual Return
+8.5%
Cumulative gain past year
| Period | AEIS Return | S&P 500 |
|---|---|---|
| 1m | -28.8% | -1.0% |
| 3m | -34.7% | -0.2% |
| 6m | -40.8% | +4.0% |
| 1y | +8.5% | +13.6% |
| ytd | -4.7% | +12.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AEIS Fundamental Analysis
The revenue trajectory is one of the strongest in the semiconductor capital equipment complex: Q3 2026 revenue of $696.4M grew 50.3% year over year versus $463.3M in Q3 2025, and the sequential cadence — $511.0M in Q1, $574.1M in Q2, $696.4M in Q3 — shows acceleration, not deceleration, with each quarter adding roughly $60-120M. Segment data for the quarter shows semiconductor equipment at $322.2M (46% of revenue), data center computing at $256.2M (37%), industrial and medical at $90.5M (13%), and telecom and networking at $27.5M (4%), confirming that AI-driven data center power and semi-cap are the twin growth engines while legacy industrial and telecom are drags. The growth trend implies the investment case has shifted from a cyclical recovery story to a structural share-gain and content-per-system story, though the concentration in two end markets raises cyclicality risk.
Profitability has inflected sharply: Q3 net income of $115.6M on a 16.6% net margin compares with $46.2M and a 10.0% margin a year ago, while gross margin expanded to 41.51% from 38.83% and operating margin reached 20.56% versus 10.62%. The margin expansion is broad-based — gross profit rose to $289.1M from $179.9M — and reflects operating leverage on the 50% revenue growth plus a richer mix toward data center and semiconductor products. EBITDA nearly tripled to $172.1M (24.7% margin) from $67.4M (14.5% margin), and with trailing net margin at 8.25% versus the quarterly run-rate of 16.6%, the annualized profitability picture is still catching up to the new run-rate, implying further earnings power if margins hold.
Balance-sheet and cash-flow quality is solid but not pristine: debt-to-equity is 0.498, the current ratio is 1.59, and cash stood at $1.43B at quarter-end after Q2's $1.13B debt repayment and $699M cash build, leaving interest coverage comfortable at roughly 47.7x on the latest quarter. Free cash flow is the soft spot — TTM FCF is just $71.8M against $115.6M of quarterly net income, with Q3 FCF of $34.0M versus operating cash flow of $65.1M as working capital absorbed $100.2M (inventory up $105.7M, receivables up $69.2M) to fund the growth surge. ROE of 10.89% and ROA of 6.25% are respectable but below what the 20%+ operating margins would suggest, reflecting the capital intensity of the working-capital build; the company can fund growth internally given its cash pile, but the FCF conversion gap is the key metric to monitor.
Quarterly Revenue
$696400000.0B
2026-09
Revenue YoY Growth
+50.3%
YoY Comparison
Gross Margin
41.5%
Latest Quarter
Free Cash Flow
$71800000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AEIS Overvalued?
Because AEIS is profitable (Q3 net income of $115.6M), the PE ratio is the primary metric, and the trailing PE of 53.0x versus a forward PE of 13.5x is the single most important valuation signal in this dataset — a 75% compression that implies the market expects earnings to roughly quadruple. That gap is corroborated by the consensus EPS estimate of $20.51 for the forward period versus the trailing EPS of $0.019 (a distorted TTM figure reflecting the depressed 2025 base), and by the PEG ratio of 0.31, which on growth-adjusted terms screens as deeply undervalued if the forward estimates are achievable.
Against its own sector and history, the picture is mixed: the PS ratio of 4.38x and EV/Sales of 4.26x are modest for a company growing revenue 50%, and the EV/EBITDA of 31.4x is elevated but defensible given EBITDA nearly tripled year over year. The P/B of 5.78x and P/CF of 33.7x sit above the 2024-2025 norms (P/B was 3.6x at end-2024 and 5.8x at end-2025), while the historical PE band shows the stock at 53.0x trailing versus 37.7x at Q4 2025 and 24.4x at Q3 2026 on the prior data cut — the trailing multiple is inflated by the low TTM earnings base, so the forward 13.5x is the more meaningful anchor. The market is pricing in optimistic but not unreasonable expectations: forward earnings must materialize for the 13.5x to hold, and any guidance miss would re-rate the stock toward the 30x+ trailing range.
Historical context reinforces that the stock is not expensive on forward numbers but is priced for execution: the forward PE of 13.5x is near the low end of AEIS's multi-year band (which ranged from roughly 18x to 53x on trailing earnings), suggesting either a genuine value opportunity or a market that doubts the durability of the earnings surge. The dividend yield of 0.20% and payout ratio of 10.5% are immaterial to the thesis, and with net margin at 8.25% trailing versus 16.6% in the latest quarter, the earnings normalization story is the crux — if Q3 margins are the new normal, the stock is cheap; if they are peak-cycle, the 13.5x forward multiple is a value trap.
PE
53.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 10x~68x
vs. Industry Avg
37.3x
Industry PE ~37.3x*
EV/EBITDA
31.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on cash conversion and end-market concentration. TTM free cash flow of just $71.8M against $115.6M of quarterly net income is a stark gap, driven by a $100.2M working-capital absorption in Q3 (inventory up $105.7M, receivables up $69.2M) that must eventually reverse or the growth is being financed rather than earned. Semiconductor equipment (46% of revenue) and data center computing (37%) together represent 83% of the top line, so a single demand air-pocket in either market would hit the majority of revenue at once, while industrial/medical (13%) and telecom (4%) are too small to cushion a downturn. Debt-to-equity of 0.498 and a current ratio of 1.59 are manageable, but the $1.43B cash pile is the main buffer against a working-capital squeeze if growth decelerates while inventory remains elevated. Market and competitive risks are dominated by valuation compression and cyclical perception. The trailing PE of 53.0x versus a forward PE of 13.5x means the market is pricing in near-quadrupling of earnings; any guidance miss would re-rate the stock toward the 30x+ trailing range, a violent move from $238.10. With a beta of 1.37, AEIS is 37% more volatile than the market, and it has already lagged SPY by 25.7 points over three months even as SPY fell only 2.0%, showing that sector rotation out of semis and AI-adjacent names hits this stock disproportionately. The 95% spread in analyst targets ($275-$535) and the lone TD Cowen Hold underscore that even the professional community cannot agree on whether the Q3 beat is a new baseline or a cyclical peak. The worst-case scenario is a specific chain: AI data center capex digests in 2027, semiconductor equipment orders slow, gross margin reverts from 41.51% toward the 37-39% historical band, and forward EPS of $20.51 proves unreachable — triggering analyst downgrades and a re-rating toward the $275 low target or below. Quantified downside is meaningful: a retest of the October closing low of $216.63 is -9.0% from $238.10, the 52-week low of $187.71 is -21.2%, and a full repeat of the -44.32% max drawdown from the current price would imply roughly $132. A more realistic adverse case is -21% to the 52-week low of $187.71, with the $275 analyst low target actually representing upside (+15.5%) rather than downside, which caps the bear case's severity relative to typical high-beta semis.
FAQ
Ranked by severity: first, margin mean-reversion — gross margin of 41.51% versus a 37-39% historical band means any reversion invalidates the 13.5x forward multiple and the $20.51 EPS estimate. Second, end-market concentration — semiconductor equipment (46%) and data center computing (37%) are 83% of revenue, so an AI infrastructure digestion phase would hit the majority of the top line at once. Third, cash conversion — TTM free cash flow of $71.8M against $115.6M of quarterly net income, with $100.2M absorbed by working capital in Q3, means growth is being financed rather than earned. Fourth, volatility and valuation compression — a beta of 1.37 and a -44.32% max drawdown show how violently the shares move, and the stock has already lagged SPY by 25.7 points over three months even as SPY fell only 2.0%.
The 12-month outlook splits into three scenarios: a 50% probability base case of $275-$388, a 25% bull case of $388-$535, and a 25% bear case of $188-$275. The base case assumes growth decelerates from 50% toward 15-25% as the semi-cap cycle normalizes, with gross margin settling in the high-30s to low-40s and the stock grinding back toward the $388.17 analyst average. The bull case requires Q4 guidance confirming the 50% run-rate as a new baseline with gross margin above 41%, driving multiple expansion toward the $535 high target. The bear case assumes AI capex digests in 2027, margins revert, and the stock retests the $216.63 October low and potentially the $187.71 52-week low. The base case is most likely, and its key assumption is that data center power demand provides a durable offset to a normalizing semiconductor equipment cycle.
The primary metric is the PE ratio, and the gap between the 53.0x trailing and 13.5x forward multiple is the single most important signal — a 75% compression that implies the market expects earnings to roughly quadruple. Supporting metrics are modest for a 50.3% grower: PS of 4.38x, EV/Sales of 4.26x, and a PEG of 0.31, though EV/EBITDA of 31.4x and P/B of 5.78x are less forgiving. Against its own history the forward 13.5x sits near the low end of a multi-year band that has ranged roughly 18x-53x on trailing earnings, so the market is paying a discount on forward numbers but a premium on book and cash flow. The valuation implies the market doubts the durability of the Q3 earnings surge — if margins are the new normal the stock is undervalued, but if Q3 was peak-cycle it is fairly-to-fully priced.
On a risk/reward basis the setup is favorable but not risk-free: 11 of 12 analysts rate AEIS Buy with a $388.17 average target, implying +63.0% upside from $238.10, and even the $275 low target sits 15.5% above the current price. The valuation anchor is a 13.5x forward PE against a 53.0x trailing multiple and a PEG of 0.31, which is cheap if the $20.51 forward EPS materializes. The biggest downside risk is margin mean-reversion — if the 41.51% gross margin falls back toward the 37-39% historical band, the forward multiple becomes a value trap, and a retest of the 52-week low of $187.71 would mean -21.2%. It is a good buy for investors with a 2-3 year horizon who can tolerate a 1.37 beta and size the position for a -44.32% max drawdown, particularly on confirmation that Q4 gross margin holds above 40%; it is not suitable for capital that may be needed within 12 months.
AEIS is better suited to a medium-to-long-term holding period of at least 18-24 months than to short-term trading. The growth stage is mid-cycle acceleration — revenue rose from $511.0M in Q1 to $574.1M in Q2 to $696.4M in Q3 2026 — but the 1.37 beta and -44.32% max drawdown mean short-term price action is dominated by semiconductor sector rotation rather than fundamentals. Earnings visibility is improving but not high: the $275-$535 analyst target range is a 95% spread, and the lone TD Cowen Hold reflects genuine debate about whether Q3 margins are a new baseline. The 0.20% dividend yield and 10.5% payout ratio provide no income support, so total return depends entirely on earnings delivery and multiple re-rating. A concrete suggestion: a minimum 18-month holding period, with position sizing that assumes a -21% to -44% drawdown is possible, and a review trigger at Q4 guidance.